Moderna Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-08-24. The offering totals $600.0M, of which $451.4M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Noubar Afeyan | Director | Cambridge, MA |
| Lee Babiss | Director | Cambridge, MA |
| Stephane Bancel | Director | Cambridge, MA |
| PETER HUTT | Director | MEDFORD, MA |
| Robert Langer | Director | Pittsburgh, PA |
| John Mendlein | Director | San Diego, CA |
| Elizabeth Nabel | Director | Seattle, WA |
| Henri Termeer | Director | Cambridge, MA |
| Stephane Bancel | Executive Officer | Cambridge, MA |
| Stephen Hoge | Executive Officer | CAMBRIDGE, MA |
| James R Kasinger | Executive Officer | Cambridge, MA |
| Lorence Kim | Executive Officer | Lexington, MA |